SBI Life Insurance Company · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
GST drag of ~110-120bps expected to continue for next 2.5 months (until mid-September) on prorated basis. Stamp duty increase also contributing to elevated other expenses corresponding to higher sums assured being written.
Individual protection AP growth at ~18% appears softer vs competitors reporting stronger numbers. Management attributes this to strategic shift toward lower-ticket pure term products (41% growth) from ROP (return of premium) products, resulting in lower absolute APE while improving product quality.
61st month persistency showing decline as COVID-era cohort (policies sold during COVID period) moves through persistency buckets. Management expects this cohort to exit by Q3 FY27, with persistency normalizing thereafter.
Analyst raised concern about differing street views on regulatory landscape for non-par products. Management remained vague, stating only that regulations will be 'for betterment' and they are 'waiting and watching' on upcoming regulatory changes.
